Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats

Fig. 2

Activity of RA-3 on IRS-1ser307 (I), p-AKT Ser473 (II), p-GSK-3β Ser9 (III) and GLUT 4 (IV) protein expression in type 2 diabetic rats. Values are expressed as the mean ± SEM (n = 5). *p ≤ 0.05, **p ≤ 0.01, ****p ≤ 0.0001 vs. non-diabetic control, ###p ≤ 0.001, ####p ≤ 0.0001 vs. diabetic control. D diabetic

Back to article page